61 – 70 of 94
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
The tyranny of the averages and the indiscriminate use of risk factors in public health : The case of coronary heart disease
(
- Contribution to journal › Article
-
Mark
Why European and United States drug regulators are not speaking with one voice on anti-influenza drugs: regulatory review methodologies and the importance of 'deep' product reviews
(
- Contribution to journal › Article
-
Mark
Intersectionality and risk of ischemic heart disease in Sweden: categorical and anti-categorical approaches
2017) IEA World Congress of Epidemiology 2017(
- Contribution to conference › Other
-
Mark
Two thirds of Survey Respondents in Southern Sweden used Complementary or Alternative Medicine (CAM) in 2015
(
- Contribution to journal › Article
- 2016
-
Mark
Regulating Pharmaceutical Industry Marketing: Development, Enforcement and Outcome of Marketing Rules
(
- Contribution to journal › Article
-
Mark
Contemporary Epidemiology : A Review of Critical Discussions Within the Discipline and A Call for Further Dialogue with Social Theory
(
- Contribution to journal › Article
-
Mark
Unhealthy marketing of pharmaceutical products: An international public health concern
(
- Contribution to journal › Article
-
Mark
Pharmaceutical Industry Off-label Promotion and Self-regulation: A Document Analysis of Off-label Promotion Rulings by the United Kingdom Prescription Medicines Code of Practice Authority 2003-2012.
(
- Contribution to journal › Article
-
Mark
Appropriate assessment of ethnic differences in adolescent use of psychotropic medication: multilevel analysis of discriminatory accuracy.
(
- Contribution to journal › Article
-
Mark
Testosterone prescribing in the population-a short social epidemiological analysis in Sweden.
(
- Contribution to journal › Article